Wall Street is positive on Acasti Pharma Inc (ACST). On average, analysts give ACST a Strong Buy rating. The average price target is $6, which means analysts expect the stock to gain by 344.44% over the next twelve months. That average ranking earns ACST an Analyst Rating of 74, which is better than 74% of stocks based on data compiled by InvestorsObserver.
Wall Street analysts are rating ACST a Strong Buy today. Find out what this means to you and get the rest of the rankings on ACST!